This latest whitepaper by regulatory experts from KGK Science explores the regulatory pathways that can be taken by manufacturers of products containing new probiotic strains to introduce them to the US and Canadian markets.
- Understanding the intersection of the science and regulation of probiotics is crucial to developing a successful path to market and reducing regulatory risk.
- Major differences exist in applicable US and Canadian regulations that govern the introduction of new probiotics into the respective jurisdiction.
- Companies considering bringing probiotic products into the market should hire a consultant to navigate the complex science and regulatory pathways.